Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatic Safety of Currently Used Antiretroviral Regimens in HIV-infected Patients With Chronic Hepatitis B and/or Hepatitis C Under Real Life Conditions: The HEPAVIR HEPATIC SAFETY Cohort.

NCT01908660 is registered in ClinicalTrials.gov with Valme University Hospital as lead sponsor.

NCT NCT01908660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01908660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatic Safety of Currently Used Antiretroviral Regimens in HIV-infected Patients With Chronic Hepatitis B and/or Hepatitis C Under Real Life Conditions: The HEPAVIR HEPATIC SAFETY Cohort.
Lead sponsor
Valme University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2007
Completion date
October 31, 2015
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic, hepatitis c, chronic, human immunodeficiency virus